Registry 17-009: Multi-Institutional Study Examining Patients With HCC Undergoing Liver Transplantation

N/AActive Not RecruitingNCT06018857

Federico Aucejo1,000 enrolled

Overview

This is a registry study examining patients with HCC undergoing liver transplantation including outcomes and predictors of recurrence

Study Type

OBSERVATIONAL

Enrollment

1,000

Conditions

Hepatocellular Carcinoma

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Adult patients (age\>18 years) undergoing Liver transplant for hepatocellular carcinoma Exclusion Criteria: * Patients under 18 years old * Patients who do not have hepatocellular carcinoma * patients who have hepatocellular carcinoma but do not undergo liver transplantation

Locations (2)

Cleveland Clinic Foundation

Cleveland, Ohio, United States

Ohio State University

Columbus, Ohio, United States

Outcomes

Primary Outcomes

Recurrence Free Survival

Time frame: From date of surgery to date of identified cancer recurrence through either clinical judgement or scans. This is assessed up to 10 years after the surgery.

Overall Survival

Time frame: From date of surgery to date of death, up to 10 years after the surgery.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.